Gontivimab
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung[1].
Product Specifications
CAS Number
1257358-38-5
Product Name Alternative
ALX-0171; VR-465
UNSPSC
12352203
Target
RSV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gontivimab.html
Purity
95.11
Solubility
10 mM in DMSO
Smiles
[Gontivimab]
References & Citations
[1]Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5;60 (1) :6-13.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7080685 Inquire
Recombinant Tscherskia triton Beta-2 adrenergic receptor (ADRB2), partial
Sign In for Pricing
View Details 
E45H04259-2 20 µg
Calcitonin (CALCA) (NM_001033952) Human Over-expression Lysate
Sign In for Pricing
View Details